TOKYO -- Japanese drugmaker Takeda Pharmaceutical said Friday it will divest its generic drug joint venture with Israeli partner Teva Pharmaceutical Industries.
Pharmaceuticals
Japan's Takeda to offload generic drug venture with Israel's Teva
Japanese private equity firm J-Will to take over Teva Takeda Pharma
Takeda Pharmaceutical said it decided to divest its generic drug joint venture due to the evolving environment in Japan's drug industry. (Photo by Kohei Yamada)
Read Next
Latest on Pharmaceuticals
